You are in Investor Relations You are in
Investor Relations

Who We Are

At 96 years old, we are one of the largest and most respected health organizations in Brazil, a reference for the medical community and the general public for our technical, medical, service and management quality. With 23,300 employees and 4,600 doctors, we have the best ESG practices and contribute to the sustainability of the healthcare system.

We are an integrated and preventive healthcare ecosystem, which was born as a clinical analysis laboratory and evolved into complete medicine offerings in its PSCs and B2B operations. We offer one of the most complete solutions in diagnostic medicine in the country, through the coordination of care centered on the individual and capacity for innovation and technology. Our brands in the individual’s health journey:

The health ecosystem is composed of three avenues of growth, namely:

  • Diagnostic Medicine: B2C with PSCs, mobile care service, B2B for hospitals and lab-to-lab for diagnostic laboratories across the country.
  • New Links: Drug Infusion, Orthopedics, Ophthalmology, Ambulatory Surgery Center and Reproductive Medicine.
  • Health Platform: B2C Marketplace with a services portfolio of medical teleconsultations, diagnostic medicine exams and low-complexity procedures.

Since 2017, ten diagnostic medicine acquisitions have been completed, which added brands, new PSCs and new operating regions, including the business combination with the Pardini Group announced in June 2022. In New Links (i.e., New Businesses), six acquisitions were completed.